Abeona Therapeutics Inc. [ABEO] shares are down more than -50.00% this year and recently increased 0.01% or $0.01 to settle at $1.51. ABEO has a short ratio of 1.21. This implies that the market is currently less bullish on the outlook for ABEO.
On 9, November 2020, Abeona Therapeutics Reports Third Quarter Financial Results. According to news published on Yahoo Finance, Conference call scheduled for Tuesday, November 10, 2020 at 8:30 a.m. ET.
Analyst Birdseye View:
The most recent analyst activity for Abeona Therapeutics Inc. [NASDAQ:ABEO] stock was on September 18, 2020, when it was Initiated with a Buy rating from B. Riley FBR, which also raised its 12-month price target on the stock to $5. Before that, on November 11, 2020, Cantor Fitzgerald Recapitulated an Overweight rating and elevated its amount target to $4. On February 10, 2020, SVB Leerink Initiated an Outperform rating and boosted its price target on this stock to $6. On December 10, 2019, Cantor Fitzgerald Resumed a Neutral rating and increased its price target from $2 to $4. On August 15, 2019, Maxim Group Downgrade a Hold rating. On August 12, 2019, Cantor Fitzgerald Downgrade a Neutral rating and boosted its amount target on this stock to $2. On July 26, 2019, Mizuho Downgrade a Neutral rating and decreased its target amount on this stock from $17 to $4. Mizuho elevated its amount target by recapitulating a higher weight for this stock.
In the past 52 weeks of trading, this stock has oscillated between a low of $0.99 and a peak of $5.19. Right now, the middling Wall Street analyst 12-month amount mark is $4.50. At the most recent market close, shares of Abeona Therapeutics Inc. [NASDAQ:ABEO] were valued at $1.51.
The Principal structure of this organization shows its whole liability to whole principal at 4.27 and the whole liability to whole assets at 3.56. It shows enduring liability to the whole principal at 3.35 and enduring liability to assets at 0.03 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 1.4600 points at 1st support level, the second support level is making up to 1.4200. But as of 1st resistance point, this stock is sitting at 1.5600 and at 1.6200 for 2nd resistance point.
Abeona Therapeutics Inc. [ABEO] reported its earnings at -$0.08 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.14/share signifying the difference of 0.06 and 42.90% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.14 calling estimates for -$0.17/share with the difference of 0.03 depicting the surprise of 17.60%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Abeona Therapeutics Inc. [NASDAQ:ABEO] is 2.70. Likewise, the Quick ratio is also the same, showing Cash ratio at 3.34. Now if looking for a valuation of this stock’s amount to book ratio is 1.53.
The most recent insider trade was by Wider Todd, Director, and it was the sale of 33876.0 shares on Dec 02. Mann Paul Elliot, the Director, completed a sale of 30488.0 shares on Dec 02. On Nov 23, Wider Todd, Director, completed a sale of 17969.0 shares.